Endoscopic Scoring System Utilization in Inflammatory Bowel Disease
1 other identifier
observational
1,500
1 country
1
Brief Summary
Inflammatory bowel diseases comprise two distinctive entities: Crohn's disease and ulcerative colitis. During the last decade, endoscopic assessment of inflammation has become relevant since it is a prognostic factor. As a consequence, therapeutic targets now contemplate mucosal healing as part of the goals to be achieved. Endoscopic scores for Crohn's disease and ulcerative colitis have been developed to objectively assess the mucosal inflammatory activity. Although they may have some limitations, these scores have been widely accepted in referral centers, especially since they have been adopted as standard evaluation in inflammatory bowel disease clinical trials . However, their use in the setting of endoscopic practice outside centers with a high volume or with less experience in clinical trials is not known.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 2, 2022
CompletedFirst Submitted
Initial submission to the registry
October 8, 2022
CompletedFirst Posted
Study publicly available on registry
October 12, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2023
CompletedDecember 28, 2022
December 1, 2022
9 months
October 8, 2022
December 26, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Endoscopic score report
Proportion of colonoscopy reports among inflammatory bowel disease patients which include an endoscopic score to assess inflammatory activity
January 2018-October 2022
Interventions
endoscopic exploration of colonic mucosa to evaluate inflammatory activity in patients with either Crohn's disease or ulcerative colitis
Eligibility Criteria
Adult patients who have already received a diagnosis of either Crohn's disease or ulcerative colitis
You may qualify if:
- Adult patients who underwent colonoscopy for the evaluation of mucosal inflammatory activity
- Patients with an established diagnosis of either Crohn's disease or ulcerative colitis
You may not qualify if:
- Sigmoidoscopies performed in ulcerative colitis for the assessment of mucosal inflammatory activity
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CEMIC
Buenos Aires, 1425, Argentina
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Juan S Lasa, MD
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 8, 2022
First Posted
October 12, 2022
Study Start
May 2, 2022
Primary Completion
January 31, 2023
Study Completion
February 20, 2023
Last Updated
December 28, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share